- Home
- LECO vs EXEL Comparison
LECO vs EXEL Comparison
Compare LECO & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LECO
- EXEL
- Stock Information
- Founded
- LECO 1895
- EXEL 1994
- Country
- LECO United States
- EXEL United States
- Employees
- LECO N/A
- EXEL N/A
- Industry
- LECO Industrial Machinery/Components
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LECO Industrials
- EXEL Health Care
- Exchange
- LECO Nasdaq
- EXEL Nasdaq
- Market Cap
- LECO 12.5B
- EXEL 10.4B
- IPO Year
- LECO N/A
- EXEL 2000
- Fundamental
- Price
- LECO $226.44
- EXEL $40.69
- Analyst Decision
- LECO Buy
- EXEL Buy
- Analyst Count
- LECO 9
- EXEL 24
- Target Price
- LECO $244.00
- EXEL $44.73
- AVG Volume (30 Days)
- LECO 349.4K
- EXEL 3.2M
- Earning Date
- LECO 10-30-2025
- EXEL 11-04-2025
- Dividend Yield
- LECO 1.39%
- EXEL N/A
- EPS Growth
- LECO 11.30
- EXEL 53.55
- EPS
- LECO 9.34
- EXEL 2.38
- Revenue
- LECO $4,176,319,000.00
- EXEL $2,288,218,000.00
- Revenue This Year
- LECO $7.79
- EXEL $9.14
- Revenue Next Year
- LECO $5.86
- EXEL $12.51
- P/E Ratio
- LECO $24.30
- EXEL $17.17
- Revenue Growth
- LECO 3.24
- EXEL 9.93
- 52 Week Low
- LECO $161.11
- EXEL $31.90
- 52 Week High
- LECO $249.19
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- LECO 38.96
- EXEL 58.21
- Support Level
- LECO $222.68
- EXEL $36.00
- Resistance Level
- LECO $231.85
- EXEL $41.55
- Average True Range (ATR)
- LECO 6.45
- EXEL 1.39
- MACD
- LECO -1.46
- EXEL 0.27
- Stochastic Oscillator
- LECO 25.04
- EXEL 87.63
About LECO Lincoln Electric Holdings Inc.
Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. Its portfolio includes arc-welding solutions, plasma and oxy-fuel cutting systems, brazing and soldering alloys, and automation solutions. Lincoln Electric serves clients across general fabrication, heavy industries, automotive, construction, shipbuilding, energy, and process industries, among others. Based in Cleveland, Lincoln Electric operates in 19 countries and employs 11,000 worldwide. The company generated roughly $4 billion in sales in 2024.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.